Net loss of Orchid Pharma reported to Rs 5.72 crore in the quarter ended September 2025 as against net profit of Rs 27.24 crore during the previous quarter ended September 2024. Sales declined 13.10% to Rs 193.52 crore in the quarter ended September 2025 as against Rs 222.70 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales193.52222.70 -13 OPM %-0.7613.62 - PBDT5.5734.53 -84 PBT-3.3325.90 PL NP-5.7227.24 PL Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live News

Orchid Pharma announced that the Annual General Meeting(AGM) of the company will be held on 20 September 2025.Powered by Capital Market - Live News

Net profit of Orchid Pharma declined 49.20% to Rs 14.91 crore in the quarter ended June 2025 as against Rs 29.35 crore during the previous quarter ended June 2024. Sales declined 29.25% to Rs 172.93 crore in the quarter ended June 2025 as against Rs 244.41 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales172.93244.41 -29 OPM %8.1913.29 - PBDT22.3736.56 -39 PBT13.7128.12 -51 NP14.9129.35 -49 Powered by Capital Market - Live News

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News